Cytotoxic Lung Endothelial Amyloids
Cytotoxic Lung Endothelial Amyloids
批准号:
9760953
负责人:
Sarah B. Voth
金额:
$2.9万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2021-08-31
关键词:
AlveolarAmyloidAmyloid beta-ProteinAttenuatedAutophagocytosisBacteriaBlood CirculationCellsClinicalComplexCritical IllnessCyclic AMPCyclic GMPCyclic NucleotidesCytosolDataDiseaseEndothelial CellsEndotheliumFloodsGasesGenerationsHealthHematogenousHourHypoxemiaImpaired cognitionInfectionInnate Immune ResponseInnate Immune SystemIntoxicationLungLung infectionsMAP3K7 geneMediatingMicrotubulesMusNeurodegenerative DisordersNosocomial pneumoniaOrganOutcomePathogenicityPathologicPathway interactionsPatientsPermeabilityPhosphorylationPhosphotransferasesPrionsProcessProductionPseudomonas aeruginosaRecyclingReportingRoleSignal TransductionTestingTransforming Growth FactorsType III Secretion System PathwayWorkantimicrobialcytotoxicexoenzymeextracellularhyperphosphorylated tauinhibition of autophagynovelpathogenpreventrespiratorytau Proteinstau aggregation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Pulmonary endothelial barrier integrity is vital for efficient gas exchange and to prevent the hematogenous
dissemination of respiratory pathogens. Pseudomonas aeruginosa, a predominant agent of nosocomial
pneumonia, breaches the endothelial barrier by inducing junctional complex disruption leading to alveolar
flooding and hypoxemia. Here, we propose to study a previously unidentified, novel disease process defined by
the interaction of the common nosocomial pathogen, P. aeruginosa, with the host endothelium. P. aeruginosa
utilizes a Type III Secretion System (T3SS) to inject cytotoxic exoenzymes directly into the host cell. Exoenzyme
Y (ExoY), a T3SS effector expressed by ~90% of clinical P. aeruginosa strains, causes marked increases in
cytosolic cGMP, cUMP, and cAMP. The increase in cAMP facilitates the phosphorylation of an endothelial tau,
which dissociates from microtubules, followed by microtubule collapse, interendothelial gap formation, and
increased permeability. Hyperphosphorylated tau then coalesces into cytotoxic tau oligomers that are released
into the extracellular milieu. These cytotoxic tau oligomers are transmissibleand self-propagating amyloid prions.
The respective roles of cGMP and cUMP are currently unknown, although preliminary data establishes both a
temporal and spatial correlation between the increase in ExoY-generated cUMP and oligomeric tau release from
PMVECs. The cUMP signal in the bulk cytosol closely coincides with both the reduction of cytosolic tau and the
concomitant increase of extracellular tau. Thus, an ExoY-instigated increase in cUMP is implicated in the export
of cytotoxic tau. Furthermore, within the context of neurodegenerative disease, the degradation and recycling
pathway of autophagy is often pathologically constrained thereby preventing the breakdown of excess or
dysregulated amyloids. Following the inhibition of autophagic flux, dysregulated amyloids accumulate and
oligomerize. Clearance of nascent tau oligomers is often facilitated via exosomal and/or secretion mediated
export. Concordant with our observations, ExoY has recently been implicated in the suppression of the innate
immune response via the inhibition of transforming growth factor-β-activating kinase 1 (TAK1) which has also
been reported to obstruct autophagy. Taken together, ExoY suppression of TAK1 in PMVECs may contribute to
the inhibition of autophagy and the production of infection-induced tau prions. Therefore, this proposal tests the
hypothesis that ExoY-induced cUMP contributes to the suppression of autophagic flux thereby promoting the
generation and release of cytotoxic tau that transmissibly disrupts interendothelial junctions and promotes
perm eability.
.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytotoxic Lung Endothelial Amyloids
-
批准号:10012762
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2019
-
负责人:Sarah B. Voth
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: